 "Trading strategies for Bata India and Alembic Pharma by Mehul Kothari")
BUY BATAINDIA NEAR Rs 1,400 | TARGET: Rs 1,560 | STOP LOSS: Rs 1,320
BATAINDIA has been correcting from 1,950 without any meaningful bounce. At this point in time, it is hovering near a rising trend line support on the weekly scale. In addition, it is on a major support of Ichimoku system on the monthly scale. We expect a decent bounce in the stock from here on. Thus, we advise traders to go long in the stock near Rs 1,400 with a stop loss of Rs 1,320.
BUY ALEMBIC PHARMA NEAR Rs 520 | TARGET: Rs 560 | STOP LOSS: Rs 500
The stock is highly oversold in most of the time frames and has started changing trend in intraday charts. The stock has retraced exactly 88.6 per cent of the previous rally and the fall seems over stretched. We expect a bounce back in the stock. Thus, we advise traders to go long in the stock near Rs 520 with a stop loss of Rs 500.
=====================================
Disclaimer: Mehul Kothari is AVP – Technical Research at Anand Rathi Shares & Stock Brokers. Views are personal
=====================================
Disclaimer: Mehul Kothari is AVP – Technical Research at Anand Rathi Shares & Stock Brokers. Views are personal
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%